These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 28818469)
1. Vaccine epidemiology: Its role in promoting sound immunization programs in Japan. Hirota Y; Ozasa K; Nakano T Vaccine; 2017 Aug; 35(36):4787-4790. PubMed ID: 28818469 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. Zimmermann U; Gavazzi G; Richard P; Eymin C; Soubeyrand B; Baudin M Vaccine; 2013 Mar; 31(11):1496-502. PubMed ID: 23313654 [TBL] [Abstract][Full Text] [Related]
3. History of influenza vaccination programs in Japan. Hirota Y; Kaji M Vaccine; 2008 Nov; 26(50):6451-4. PubMed ID: 18573292 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study. Tregnaghi MW; Stamboulian D; Vanadía PC; Tregnaghi JP; Calvari M; Fragapane E; Casula D; Pellegrini M; Groth N Viral Immunol; 2012 Jun; 25(3):216-25. PubMed ID: 22691101 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484 [TBL] [Abstract][Full Text] [Related]
6. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ; MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16. Nohynek H; Baum U; Syrjänen R; Ikonen N; Sundman J; Jokinen J Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684447 [TBL] [Abstract][Full Text] [Related]
8. The use of inactivated influenza vaccine in children. Wright PF Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Adegbola R; Nesin M; Wairagkar N Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S28-32. PubMed ID: 22920055 [TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients. Van Hoecke C; Prikazsky V; Utö I; Menschikowski C Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. Peeters M; Regner S; Vaman T; Devaster JM; Rombo L Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014 [TBL] [Abstract][Full Text] [Related]
13. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Plennevaux E; Blatter M; Cornish MJ; Go K; Kirby D; Wali M; Reeves-Hoché MK; Denis M Vaccine; 2011 Feb; 29(8):1569-75. PubMed ID: 21219979 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan. Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602 [TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Mutsaerts E; Madhi SA; Cutland CL; Jones S; Hugo A; Trenor S; Treurnicht FK; Klipstein-Grobusch K; Weinberg A; Nunes MC Expert Rev Vaccines; 2016 Aug; 15(8):1055-62. PubMed ID: 27212228 [TBL] [Abstract][Full Text] [Related]
16. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. Halasa NB; Gerber MA; Berry AA; Anderson EL; Winokur P; Keyserling H; Eckard AR; Hill H; Wolff MC; McNeal MM; Edwards KM; Bernstein DI J Pediatric Infect Dis Soc; 2015 Sep; 4(3):214-24. PubMed ID: 26334249 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Torii Y; Kimura H; Ochi N; Kaneko K; Ando H; Kiuchi T; Ito Y Vaccine; 2011 Jun; 29(25):4187-9. PubMed ID: 21513762 [TBL] [Abstract][Full Text] [Related]
18. Control of influenza and poliomyelitis with killed virus vaccines. Salk J; Salk D Science; 1977 Mar; 195(4281):834-47. PubMed ID: 320661 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Katayose M; Hosoya M; Haneda T; Yamaguchi H; Kawasaki Y; Sato M; Wright PF Vaccine; 2011 Feb; 29(9):1844-9. PubMed ID: 21195802 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial. Wu UI; Hsieh SM; Lee WS; Wang NC; Kung HC; Ou TY; Chen FL; Lin TY; Chen YC; Chang SC Vaccine; 2017 Jul; 35(33):4099-4104. PubMed ID: 28668573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]